Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care - Correlations with food intake, metabolism, exercise capacity, and hormones

Cancer

Volumn 103, Issue 10, 2005, Pages 2189-2198

  Fouladiun, Marita ^a   Körner, Ulla ^a   Bosaeus, Ingvar ^a   Daneryd, Peter ^a   Hyltander, Anders ^a   Lundholm, Kent G ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Body composition; Body fat; Cancer cachexia; Lean tissue; Palliative care

Indexed keywords

C REACTIVE PROTEIN; GHRELIN; HORMONE; INSULIN; LEPTIN; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BILIARY TRACT TUMOR; BODY COMPOSITION; BODY FAT; BODY WEIGHT; BREAST TUMOR; CACHEXIA; CALORIC INTAKE; CALORIMETRY; CANCER PALLIATIVE THERAPY; COLORECTAL TUMOR; DIETARY INTAKE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY EXPENDITURE; ERYTHROCYTE SEDIMENTATION RATE; EXERCISE; FEMALE; FOLLOW UP; FOOD INTAKE; GASTROINTESTINAL TUMOR; HUMAN; INSULIN BLOOD LEVEL; LEAN BODY WEIGHT; LEG; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; MELANOMA; METABOLISM; PANCREAS TUMOR; PRIORITY JOURNAL; TRUNK; WALKING; WEIGHT REDUCTION;

ADIPOSE TISSUE; AGED; BLOOD SEDIMENTATION; BODY COMPOSITION; C-REACTIVE PROTEIN; COHORT STUDIES; DIETARY CARBOHYDRATES; DIETARY FATS; EATING; ENERGY INTAKE; ENERGY METABOLISM; EXERCISE TOLERANCE; FOLLOW-UP STUDIES; HORMONES; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LONGITUDINAL STUDIES; MUSCLE, SKELETAL; NEOPLASMS; PALLIATIVE CARE; PEPTIDE HORMONES; SERUM ALBUMIN; SURVIVAL RATE; WEIGHT LOSS;

EID: 18044361914     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21013     Document Type: Article

References (56)

1. Hyltander A, Drott C, Unsgaard B, et al. The effect on body composition and exercise performance of home parenteral nutrition when given as adjunct to chemotherapy of testicular carcinoma. Eur J Clin Invest. 1991;21:413-420.
2. Lindmark L, Bennegard K, Eden E, et al. Resting energy expenditure in malnourished patients with and without cancer. Gastroenterology. 1984;87:402-408.
3. Arbeit JM, Lees DE, Corsey R, Brennan MF. Resting energy expenditure in controls and cancer patients with localized and diffuse disease. Ann Surg. 1984;199:292-298.
4. Dempsey DT, Feurer ID, Knox LS, Crosby LO, Buzby GP, Mullen JL. Energy expenditure in malnourished gastrointestinal cancer patients. Cancer. 1984;53:1265-1273.
5. Dempsey DT, Knox LS, Mullen JL, Miller C, Feurer ID, Buzby GP. Energy expenditure in malnourished patients with colorectal cancer. Arch Surg. 1986;121:789-795.
6. Simons JP, Schols AM, Buurman WA, Wouters EF. Weight loss and low body cell mass in males with lung cancer: relationship with systemic inflammation, acute-phase response, resting energy expenditure, and catabolic and anabolic hormones. Clin Sci (Lond). 1999;97:215-223.
7. Bosaeus I, Daneryd P, Svanberg E, Lundholm K. Dietary intake and resting energy expenditure in relation to weight loss in unselected cancer patients. Int J Cancer. 2001;93:380-383.
8. Warnold I, Lundholm K, Schersten T. Energy balance and body composition in cancer patients. Cancer Res. 1978;38:1801-1807.
9. Bruning PF, Egger RJ, Gooskens AC, et al. Dietary intake, nutritional status and well-being of cancer patients: a prospective study. Eur J Cancer Clin Oncol. 1985;21:1449-1459.
10. De Cicco M, Bortolussi R, Fantin D, et al. Supportive therapy of elderly cancer patients. Crit Rev Oncol Hematol. 2002;42:189-211.
11. Lundholm K, Daneryd P, Körner U, Hyltander A, Bosaeus I. Evidence that long-term COX-treatment improves energy homeostasis and body composition in cancer patients with progressive cachexia. Int J Oncol. 2004;24:505-512.
12. Daneryd P, Svanberg E, Körner U, et al. Protection of metabolic and exercise capacity in unselected weight-losing cancer patients following treatment with recombinant erythropoietin: a randomized prospective study. Cancer Res. 1998;58:5374-5379.
13. Lundholm K, Daneryd P, Bosaeus I, Körner U, Lindholm E. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: effects on survival, metabolism, and function. A randomized prospective study. Cancer. 2004;100:1967-1977.
14. Lindholm E, Daneryd P, Körner U, Hyltander A, Fouladiun M, Lundholm K. Effects of recombinant erythropoietin in palliative treatment of unselected cancer patients. Clin Cancer Res. 2004;10:6855-6864.
15. Hâglin L, Hagman U, Nilsson M. Evaluation of the meal model "Matmallen." A means of estimating consumed amounts of food. Scand J Nutr. 1995;39:79-83.
16. Livsmedelsverk S. Food composition tables-energy and nutrients. Uppsala: Swedish National Food Administration, 1993.
17. Bingham SA, Cummings JH. Urine nitrogen as an independent validatory measure of dietary intake: a study of nitrogen balance in individuals consuming their normal diet. Am J Clin Nutr. 1985;42:1276-1289.
18. Lindmark L, Ekman L, Lundholm K. A simplified technique for measurements of energy expenditure and substrate oxidation in man. Clin Physiol. 1985;5:337-345.
19. Shizgal HM. Body composition of patients with malnutrition and cancer. Summary of methods of assessment. Cancer. 1985;55(1 Suppl):250-253.
20. Maturo G, Vespasiani G, Mohamed EI, et al. Evaluating body composition of Italian prostate cancer patients without metastases. Acta Diabetol. 2003;40(Suppl 1):S168-S170.
21. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21:1653-1659.
22. Sarhill N, Mahmoud F, Walsh D, et al. Evaluation of nutritional status in advanced metastatic cancer. Support Care Cancer. 2003;11:652-659.
23. McMillan DC, Preston T, Watson WS, et al. Relationship between weight loss, reduction of body cell mass and inflammatory response in patients with cancer. Br J Surg. 1994;81:1011-1014.
24. Moley JF, Aamodt R, Rumble W, Kaye W, Norton JA. Body cell mass in cancer-bearing and anorexic patients. JPEN J Parenter Enteral Nutr. 1987;11:219-222.
25. Burke M, Bryson EI, Kark AE. Dietary intakes, resting metabolic rates, and body composition in benign and malignant gastrointestinal disease. BMJ. 1980;280:211-215.
26. Hansen RD, Raja C, Allen BJ. Total body protein in chronic diseases and in aging. Ann NY Acad Sci. 2000;904:345-352.
27. MacFie J, Burkinshaw L. Body composition in malignant disease. Metabolism. 1987;36:290-294.
28. Smith MR, Finkelstein JS, McGovern FJ, et al. Changes in body composition during androgen deprivation therapy for prostate cancer. J Clin Endocrinol Metab. 2002;87:599-603.
29. Simons JP, Schols AM, Westerterp KR, ten Velde GP, Wouters EF. The use of bioelectrical impedance analysis to predict total body water in patients with cancer cachexia. Am J Clin Nutr. 1995;61:741-745.
30. Fredrix EW, Saris WH, Soeters PB, et al. Estimation of body composition by bioelectrical impedance in cancer patients. Eur J Clin Nutr. 1990;44:749-752.
31. Koch J. The role of body composition measurements in wasting syndromes. Semin Oncol. 1998;25(2 Suppl 6):12-19.
32. Heymsfield SB, McManus CB. Tissue components of weight loss in cancer patients. A new method of study and preliminary observations. Cancer. 1985;55(1 Suppl):238-249.
33. Cohn SH, Ellis KJ, Vartsky D, et al. Comparison of methods of estimating body fat in normal subjects and cancer patients. Am J Clin Nutr. 1981;34:2839-2847.
34. Ali PA, al-Ghorabie FH, Evans CJ, el-Sharkawi AM, Hancock DA. Body composition measurements using DXA and other techniques in tamoxifen-treated patients. Appl Radiat Isot. 1998;49(5-6):643-645.
35. Watson WS, Sammon AM. Body composition in cachexia resulting from malignant and non-malignant diseases. Cancer. 1980;46:2041-2046.
36. Lundholm K, Gelin J, Hyltander A, et al. Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res. 1994;54:5602-5606.
37. Heymsfield SB, McManus C, Stevens V, Smith J. Muscle mass: reliable indicator of protein-energy malnutrition severity and outcome. Am J Clin Nutr. 1982;35(5 Suppl):1192-1199.
38. Briet F, Twomey C, Jeejeebhoy KN. Relationship between metabolism and peripheral blood mononuclear cell mitochondrial complex I activity before and after a short-term refeeding in weight-losing cancer patients. Clin Nutr. 2003;22:247-253.
39. Svaninger G, Bennegard K, Ekman L, Ternell M, Lundholm K. Lack of evidence for elevated breakdown rate of skeletal muscles in weight-losing, tumor-bearing mice. J Natl Cancer Inst. 1983;71:341-346.
40. Bennegard K, Eden E, Ekman L, Schersten T, Lundholm K. Metabolic balance across the leg in weight-losing cancer patients compared to depleted patients without cancer. Cancer Res. 1982;42:4293-4299.
41. Bennegard K, Lindmark L, Eden E, Svaninger G, Lundholm K. Flux of amino acids across the leg in weight-losing cancer patients. Cancer Res. 1984;44:386-393.
42. Lundholm K, Karlberg I, Ekman L, Edstrom S, Schersten T. Evaluation of anorexia as the cause of altered protein synthesis in skeletal muscles from nongrowing mice with sarcoma. Cancer Res. 1981;41:1989-1996.
43. Strasser F, Bruera ED. Update on anorexia and cachexia. Hematol Oncol Clin North Am. 2002;16:589-617.
44. Moller-Loswick AC, Bennegard K, Lundholm K. The forearm and leg perfusion techniques in man do not give the same metabolic information. Clin Physiol. 1991;11:385-395.
45. Douchi T, Ijuin H, Nakamura S, Oki T, Maruta K, Nagata Y. Correlation of body fat distribution with grade of endometrial cancer. Gynecol Oncol. 1997;65:138-142.
46. Lundholm K, Edstrom S, Ekman L, Karlberg I, Bylund AC, Schersten T. A comparative study of the influence of malignant tumor on host metabolism in mice and man: evaluation of an experimental model. Cancer. 1978;42:453-461.
47. Ternell M, Lonnroth C, Lundholm K. Nuclear RNA polymerase activity in tumor-host livers. Am J Physiol. 1985;249(5 Pt 1):E461-E469.
48. Wigmore SJ, Falconer JS, Plester CE, et al. Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients. Br J Cancer. 1995;72:185-188.
49. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition. 1996;12(1 Suppl):S27-S30.
50. Zuijdgeest-van Leeuwen SD, van den Berg JW, Wattimena JL, et al. Lipolysis and lipid oxidation in weight-losing cancer patients and healthy subjects. Metabolism. 2000;49:931-936.
51. Korber J, Pricelius S, Heidrich M, Muller MJ. Increased lipid utilization in weight losing and weight stable cancer patients with normal body weight. Eur J Clin Nutr. 1999;53:740-745.
52. Fredrix EW, Staal-van den Brekel AJ, Wouters EF. Energy balance in nonsmall cell lung carcinoma patients before and after surgical resection of their tumors. Cancer. 1997;79:717-723.
53. Crown AL, Cottle K, Lightman SL, et al. What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? Clin Endocrinol (Oxf). 2002;56:723-733.
54. May PE, Barber A, D'Olimpio JT, Hourihane A, Abumrad NN. Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg. 2002;183:471-479.
55. Giacosa A, Frascio F, Sukkar SG, Roncella S. Food intake and body composition in cancer cachexia. Nutrition. 1996;12(1 Suppl):S20-S23.
56. Nelson LH, Tucker LA. Diet composition related to body fat in a multivariate study of 203 men. J Am Diet Assoc. 1996;96:771-777.